About ImQuest Pharma Therapeutic Focus Product Pipeline Scientific Staff News & Notes Investor Relation Contact Us Careers
  
 
Therapeutic Focus
General Information
Infectious Disease
Cancer
Topical Microbicides
Immune Modulation and
Inflammation
News and Notes
April 4th 2008:
ImQuest scientists present important HIV Microbicide results at Microbicides 2008 in Delhi, India.
   
April 1st 2008:
ImQuest publishes results of structure activity relationship study with pyrimidinedione HIV inhibitors.
   
September 24th 2007:
ImQuest Life Sciences announces the appointment of Robert Schooley, M.D. to its Scientific Advisory Board.
   
September 21st 2007:
ImQuest Life Sciences announces the appointment of David Ho, M.D. to its Scientific Advisory Board.
   
September 20th 2007:
ImQuest Life Sciences announces the appointment of Richard J. Whitley, M.D. as Chairman of its Scientific Advisory Board.
   
April 25th 2007:
ImQuest Life Sciences Receives Grant from International Partnership
for Microbicides to Develop Novel Microbicide
   
April 25th 2006:
ImQuest Life Sciences Licenses Piperazine Series of Anti-Cancer Therapeutic
Compounds from Samjin Pharmaceutical Co.
   
 News Archieve
Welcome to ImQuest Life Sciences
 
* Email:
* First Name:
* Last Name:
* Comments:
  Cancel
 
 
Meet ImQuest Life Sciences's Staff at the Following Scientific Meetings:

International Conference on Antiviral Research (Palm Springs, CA, May 2007)

American Association of Pharmaceutical Science-Biotechnology (San Diego, CA June 2007)

DART-HIV (Cancun, Mexico, December 2006)

Internscience Conference of Antimicrobial Agents and Chemotherapy (Chicago, September 2007)

DART-HCV (Hawaii, December 2007)

 
Copyright © 2006, ImQuest Life Sciences. Site Map | Search | Privacy Policy | Terms & Conditions. Site by Synapse Communications.